FDA Investigator Randa Melhem, PhD
Randa Melhem, PhD has conducted inspections on 18 sites in 9 countries as of 29 Jul 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
18
Last Inspection Date:
29 Jul 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Israel,
France,
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Denmark,
Sweden,
Austria,
Switzerland,
Belgium
FDA Investigators that have inspected at least one site in common with Randa Melhem, PhD:
Abby Lmozeke Baker,
Alan L Truong,
Albert F Peacock, PhD,
Andrey Sarafanov, PhD,
Anissa M Cheung,
Ann Marie Montemurro,
Ann Marie Schofield,
Anthony F Lorenzo,
Arie C Menachem,
Ashley J Burns,
Brentley S Collins,
Burnell M Henry,
CDR Cecily Jones,
CDR Jeremy L Wally, PhD,
Chad R Burger,
Chava Kimchi Sarfaty, PhD,
Christian D Lynch (CDL),
Colleen F Hoyt,
Cynthia Jim, CSO,
David M Beltran,
Deborah M Trout,
Denis Gavin, PhD,
Destry M Sillivan,
Dr. Gang Wang, PhD,
Eileen A Liu,
Ekaterina Allen,
Eliezar Ramos,
Esra Toussaint,
Freddy Ortiz Colon,
Gene D Arcy,
Haruhiko Murata,
Helen B Ricalde,
J David Doleski,
Jacqueline Mdiaz Albertini,
James A Crim,
Jean Lhu Primmer,
Jennifer L Reed,
Jie He,
Joan A Loreng,
Joan Johnson,
Joan M Cantellops Figueroa,
John M Mcinnis,
Joseph George,
Justin A Boyd,
Keith Wonnacott, PhD,
Kimberly L Schultz,
Laurel A Beer,
Laurimer Kuilan Torres,
LCDR Debra Emerson,
Lewis K Antwi,
Lily Y Koo,
Lu Deng,
Malgorzata G Norton, PhD,
Mariza M Jafary,
Mark I Schwartz,
Mary P Padgett,
Mercy O Quagraine,
Michael C Kennedy, PhD,
Michael J Vardon,
Michele L Forster, PhD,
Michele Perry Williams,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Minh D Phan,
Mizanne E Lewis,
Mra Munizn,
Nancy Kirschbaum, PhD,
Nancy T Waites,
Nawab A Siddiqui,
Nicole K Trudel,
Nimmy Mathews,
Nobuko H Katagiri,
Olga Simakova, PhD,
Omotunde O Osunsanmi,
Pankaj H Amin,
Parul M Patel,
Paul W Keller,
Paula A Trost,
Penny H Mccarver,
Prabhu P Raju,
Priscilla M Pastrana,
Randy L Clarida,
Rebecca K Olin,
Richard W Thornton,
Robert D Tollefsen,
Roger F Zabinski,
Rose Ashley,
Sangeeta M Khurana, PhD,
Scott T Ballard,
Seneca D Toms,
Sherry G Bous,
Sidney B Priesmeyer,
Simone E Pitts,
Steven A Rubin,
Steven E Bowen, PhD,
Steven Oh, PhD,
Sukhanya Jayachandra,
Susan M Jackson,
Thai D Truong,
Thomas Finn, PhD,
Toyin B Oladimeji,
Unnee Ranjan,
Viviana R Ramirez,
Xianghong Jing (Emily), PhD,
Xiao Wang,
Xiaobin Lu (Victor), PhD,
Yasamin Ameri,
Yiping Jia,
Yonggang Wang, PhD,
Ze Peng,
Zuben E Sauna, PhD
Randa Melhem, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2016 | FDA 483 | BAXALTA US INC. - Form 483, 2016-06-24 |
| January, 2010 | FDA 483 | Dendreon Corporation - Form 483, 2010-01-29 |
| April, 2017 | FDA 483 Response | Novartis Pharmaceuticals Corporation - Form 483R, 2017-04-21 |
| January, 2010 | FDA 483 | Dendreon Corporation - Form 483, 2010-01-29 |
| April, 2017 | FDA 483 | Novartis Pharmaceuticals Corporation - Form 483, 2017-04-07 |
| April, 2017 | EIR | Novartis Pharmaceuticals Corporation - EIR, 2017-04-07 |
| January, 2010 | EIR | Dendreon Corporation - EIR, 2010-04-23 |
| July, 2012 | FDA 483 | Octapharma AB - Form 483, 2012-07-30 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more